Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development of biomarkers to optimize pediatric patient management: what makes children different?

Biomarkers in medicine - 1 Dec 2011

Goldman Jennifer, Becker Mara L, Jones Bridgette, Clements Mark, Leeder J Steven

Abstract excerpt

Despite the frequent utilization of biomarkers in medical practice, there is a relative paucity of information regarding validated pediatric biomarkers. Frequently, biomarkers found to be efficacious in adults are extrapolated to the pediatric clinical setting without considering that the pathogenesis of many diseases is distinctly different in children, and ontogeny directly influences disease evolution and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arthritis, Juvenile
Share to Biomarkers
Share to Child

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Folic Acid

Share to Methotrexate

Share to Pediatrics

Share to Pharmacogenetics

Share to Reference Values

Source

Open in PubMed Open full text

Identifiers

PMID: 22103612
DOI: 10.2217/bmm.11.96
PMCID: PMC3321646

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development of biomarkers to optimize pediatric patient management: what makes children different?PMID 22103612Read ↗

The Barker hypothesis: how pediatricans will diagnose and prevent common adult-onset diseases.Semantic proximity Read ↗

[Knowledge about genotype-phenotype of the diseases should be coming into pediatrician's horizon].Semantic proximity Read ↗

Molecular Markers of Pediatric Solid Tumors—Diagnosis, Optimizing Treatments, and Determining Susceptibility: Current State and Future DirectionsSemantic proximity Read ↗

Precision diagnostics in childrenSemantic proximity Read ↗

Pharmacogenomic biomarker information in FDA-approved paediatric drug labels.Semantic proximity Read ↗

Biomarkers in Childhood-Onset Systemic Lupus Erythematosus.Semantic proximity Read ↗

Biomarkers for assessing reproductive development and health: Part 1--Pubertal development.Semantic proximity Read ↗

Paediatrics: genetic insights and long-term follow-up.Semantic proximity Read ↗

Interstitial Lung Disease in Children Younger Than 2 Years.Semantic proximity Read ↗

Proteomic profiling reveals diagnostic signatures and pathogenic insights in multisystem inflammatory syndrome in childrenSemantic proximity Read ↗

Proteomic signatures of pediatric cardiovascular and cardiometabolic traits demonstrate long-term modifiable drivers of adult diseaseSemantic proximity Read ↗

Blood cytometry, neutrophil-lymphocyte index and platelet-lymphocyte index in children with high-risk pathologies and COVID-19Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.